Chelating Agents for Zirconium-89 in the Synthesis of Radiopharmaceuticals: Current State and Prospects of Development

V. B. Bubenshchikov,A. A. Larenkov

DOI: https://doi.org/10.1134/S1070328422110021

2022-11-03

Russian Journal of Coordination Chemistry/Koordinatsionnaya Khimiya

Abstract:Zirconium is a highly demanded element widely used in various fields of science and technology. There are 39 known zirconium isotopes, among which zirconium-89 ( T 1/2 = 78.42 h) attracts increasing attention of the scientific community in connection with the radionuclide diagnostics of various diseases. The radiopharmaceuticals based on 89 Zr are currently actively developed and introduced into clinical practice. The 89 Zr isotope is in demand to develop agents based on monoclonal antibodies, which are mainly used for cancer diagnosis and therapy monitoring. For incorporation of 89 Zr into vector molecules that would allow selective isotope accumulation in various foci, an appropriate chelating agent is required. Furthermore, specific features of application of zirconium-89 complexes in radiopharmaceuticals impose additional requirements on the chelator properties. First, this is high complex formation efficiency without heating of the reaction mixture at approximately neutral pH. Also, the complexes should be stable not only in vitro, but also in vivo. The main difficulty hampering the design of new chelators is the intricate coordination chemistry of zirconium, that is, the formation of polynuclear species with different degrees of polymerization and composition varying depending on pH and time. Therefore, conventional techniques such as EXAFS, X-ray diffraction, and potentiometric titration in aqueous media are often of low utility, and chemists have to resort to some alternative methods for studying these compounds. Thus, the integration of experimental data from various sources is of high practical value. The review discusses problems associated with the use of the popular chelator deferoxamine, recent advances in the search and synthesis of new chelators, and the application of various methods to evaluate the applicability of the obtained complexes for advanced nuclear medicine procedures.